A cancer therapy that removes malignant cells from a patient’s cerebrospinal fluid may soon be available to prevent metastases and decrease complications of cancers involving the brain, according to Penn State medical researchers.
A cancer therapy that removes malignant cells from a patient’s cerebrospinal fluid may soon be available to prevent metastases and decrease complications of cancers involving the brain, according to Penn State medical researchers.